Bio Green Med Solution, Inc. (BGMS) vs Evogene Ltd. (EVGN)

Bio Green Med Solution, Inc. and Evogene Ltd. are both Biotechnology companies. Bio Green Med Solution, Inc. and Evogene Ltd. are of similar size ($6.3M and $6.2M). Bio Green Med Solution, Inc. grew revenue faster over the last twelve months: 2,414.9% against −54.7%. Evogene Ltd. has the higher net margin (−547.6% vs −715.5%) and the higher return on invested capital (0.00% vs −67.3%). Across the 17 metrics below, Bio Green Med Solution, Inc. leads on 10 and Evogene Ltd. on 7.

Valuation

Metric BGMS EVGN Biotechnology median
P/E n/m n/m 7.88
P/S 2.77 3.09 11.47
P/B 0.72 0.89 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.39 0.74
EV/Sales 0.73 (2.55) 10.73
Earnings yield (395.65%) (216.67%) (28.84%)
Free cash flow yield (19.45%) (210.40%) (23.03%)

Profitability

Metric BGMS EVGN Biotechnology median
Gross margin 19.34% (67.59%) 65.16%
Operating margin (194.95%) (851.42%) 0.00%
Net margin (715.48%) (547.62%) 0.00%
Free cash flow margin (59.00%) (650.63%) 0.00%
Return on equity (246.85%) (100.03%) (57.72%)
Return on assets (217.30%) (38.31%) (49.22%)
Return on invested capital (67.28%) 0.00% 0.00%

Growth

Metric BGMS EVGN Biotechnology median
Revenue growth (TTM) 2,414.86% (54.71%) 5.64%
EPS growth (last fiscal year) 98.71% 62.63% —
Revenue growth, 5-year CAGR (17.41%) 29.94% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BGMS EVGN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.63 3.57 4.73
Net debt to EBITDA 0.42 1.12 0.96

Dividend

Metric BGMS EVGN Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric BGMS EVGN Biotechnology median
Market cap 6.16m 6.32m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack